BLGO — BIOLARGO, INC.
—
OTC ·
Materials ·
Chemicals ·
CIK 880242 ·
Last close
$0.14
Market Cap
$43.32M
52W High
$0.18
52W Low
$0.11
ADV30
394,700
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 1,115,000 | 458,000 | -3,204,000 | -2,286,000 | 8,565,000 | 4,122,000 | 8,752,000 |
| Dec 2025 | 617,000 | 128,000 | -3,997,000 | -2,953,000 | 8,311,000 | 3,883,000 | 6,785,000 |
| Sep 2025 | 1,103,000 | 372,000 | -7,180,000 | -6,479,000 | 9,130,000 | 4,546,000 | 5,915,000 |
| Jun 2025 | 2,777,000 | 1,421,000 | -1,802,000 | -1,192,000 | 12,499,000 | 3,471,000 | 6,439,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-8,297,000
Investing CF
$435,000
Financing CF
$8,221,000
CapEx
$-52,000
Dividends Paid
—
Buybacks
$-15,000
EPS Diluted TTM
$-0.03
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-161,280,000
Inventory
$310,000
Receivables
$615,000
ST Investments
—
EBIT TTM
$-14,712,000
Pretax Income TTM
$-15,189,000
Interest Exp TTM
$477,000
Analysts
1
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 7,765,000 | -14,835,000 | -11,780,000 | 8,311,000 | 6,785,000 | — | -8,297,000 |
| Dec 2024 | 17,779,000 | -4,305,000 | -2,402,000 | 10,513,000 | 4,457,000 | — | -3,206,000 |
| Dec 2023 | 12,230,000 | -4,163,000 | -3,504,000 | 8,205,000 | 4,003,000 | — | -2,365,000 |
| Dec 2022 | 5,884,000 | -5,056,000 | -4,473,000 | 4,858,000 | 2,847,000 | — | -2,762,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.04
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BIOF | BLUE BIOFUELS, INC. | $45.16M | $0.14 | — |
| LEEEF | Leef Brands Inc. | $40.65M | $0.14 | — |
| AXIL | Axil Brands, Inc. | $47.86M | $7.02 | — |
| VGAS | Verde Clean Fuels, Inc. | $38.15M | $1.73 | — |
| CXXIF | C21 Investments Inc. | $32.85M | $0.28 | — |
News headlines (Yahoo Finance, 1h cache)
BioLargo Subsidiary Clyra Medical Signs Exclusive Distribution Agreement with Al- Hikma FZCO for ViaCLYR(TM) Across the Middle East, North Africa, and Adjacent Markets
2026-05-05 07:00 · Yahoo
BioLargo Signs Memorandum of Understanding with Aquatech to Accelerate Commercialization of PFAS Treatment Technology
2026-05-04 09:00 · Yahoo
BioLargo to Participate in a Town Hall Meeting Hosted by the BioLargo Shareholder Community on Discord on May 5, 2026
2026-05-04 08:00 · Yahoo
BioLargo Engineering, Science & Technologies Awarded $1.2 Million Contract to Design Pilot-Scale Minerals Processing Facility for Resource Recovery
2026-04-20 13:33 · Yahoo
BioLargo CEO Dennis Calvert to Present Global Environmental Leadership Award to Robert Bilott at Nassau County PFAS Forum
2026-04-01 15:05 · Yahoo
BioLargo Inc (BLGO) Q4 2025 Earnings Call Highlights: Strategic Shifts and Financial Challenges
2026-03-05 23:01 · Yahoo
BioLargo Reports Annual 2025 Operating and Financial Results
2026-03-05 14:35 · Yahoo
BioLargo Q4 2025 and Year End Earnings Results Webcast and Conference Call on Thursday, March 5th, 2026 - 12:00 PM Eastern Time
2026-03-04 15:30 · Yahoo
BioLargo Subsidiary Clyra Medical Highlights Key Opinion Leader Presentation of Exceptional ViaCLYR(TM) Clinical Results at Leading Wound Care Symposium
2026-02-18 12:10 · Yahoo
BioLargo Subsidiary Clyra Medical Technologies Secures First Stocking Order with Advanced Solution for ViaCLYR(TM) Wound Irrigation Solution
2026-02-09 14:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.